Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01287897
What this trial is testing

Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

Who this might be right for
Crohn's Disease
Pfizer 250
Not applicableUnknownNCT06107179
What this trial is testing

Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography

Who this might be right for
Crohn DiseaseUlcerative ColitisInflammatory Bowel Diseases
University of Erlangen-Nürnberg Medical School 50
Not applicableStudy completedNCT03059394
What this trial is testing

Validation of Rehab Assessments in Myositis Patients

Who this might be right for
Myositis
University of Zurich 50
Testing effectiveness (Phase 2)Ended earlyNCT00130390
What this trial is testing

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Who this might be right for
Crohn's Disease
Romark Laboratories L.C. 98
Not applicableUnknownNCT03735524
What this trial is testing

Exercise-based Therapy for Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Neuromed IRCCS 35
Not applicableStudy completedNCT00955123
What this trial is testing

Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Active Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
University of Aarhus 40
Not applicableUnknownNCT03839680
What this trial is testing

Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centre Hospitalier Universitaire de Besancon 60
Not applicableStudy completedNCT02740686
What this trial is testing

Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Lincoln 85
Testing effectiveness (Phase 2)Study completedNCT02321280
What this trial is testing

The Efficacy of Denosumab in Active Crohn's Disease

Who this might be right for
Crohn Disease
University of Manitoba 2
Not applicableActive Not RecruitingNCT02130362
What this trial is testing

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,446
Large-scale testing (Phase 3)UnknownNCT03716388
What this trial is testing

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
Dayanand Medical College and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02888379
What this trial is testing

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Topivert Pharma Ltd 77
Large-scale testing (Phase 3)Study completedNCT01951326
What this trial is testing

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Who this might be right for
Crohn's Disease
RedHill Biopharma Limited 331
Testing effectiveness (Phase 2)Looking for participantsNCT06453317
What this trial is testing

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel Diseases
Medical University of Lodz 172
Large-scale testing (Phase 3)Study completedNCT00028327
What this trial is testing

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Early research (Phase 1)Ended earlyNCT02000453
What this trial is testing

Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 2
Not applicableStudy completedNCT03781284
What this trial is testing

PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Universität Duisburg-Essen 53
Large-scale testing (Phase 3)Looking for participantsNCT06937099
What this trial is testing

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Who this might be right for
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company 290
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Large-scale testing (Phase 3)Ended earlyNCT01362608
What this trial is testing

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 136
Next Page